СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY?
Concomitant administration of clopidogrel and proton pump inhibitors (PPI), the possible influence of PPI on the effectiveness of clopidogrel often raises questions among practitioners. Massive antithrombotic therapy increases the risk of upper gastrointestinal tract lesions. Concomitant administrat...
Main Authors: | S. Yu. Martsevich, A. Yu. Suvorov |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/307 |
Similar Items
-
СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY?
by: S. Yu. Martsevich, et al.
Published: (2015-09-01) -
Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
by: Yong Kang Lee, et al.
Published: (2023-08-01) -
Ilaprazole and Clopidogrel Resistance in Acute Stroke Patients
by: In Hwan Lim, et al.
Published: (2022-06-01) -
In-hospital gastric protection with proton pump inhibitors: adverse effects beyond (over)utilization?
by: Paolo Montanari
Published: (2013-04-01) -
Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug Therapy
by: Niels Westergaard, et al.
Published: (2021-02-01)